Literature DB >> 14730434

Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan.

Akira Sudo1,2, Shiho Honzawa1,3, Ikuya Nonaka2, Yu-Ichi Goto4.   

Abstract

The mitochondrial DNA (mtDNA) G13513A mutation in the ND5 subunit gene has been recently reported as a common cause of some phenotypes of mitochondrial myopathy. Until now, the prevalence and characteristics of this mutation in Leigh syndrome (LS) has not been determined. We screened 84 patients with Leigh syndrome (LS) and found the mutation in six (7%) of them. The proportions of mutant mtDNA in muscles were relatively low (42-70%). The onset of symptoms for patients with this mutation was from 9 months to 5 years. It should be noted that five patients had cardiac conduction abnormalities, particularly Wolff-Parkinson-White (WPW) syndrome (three patients). This study suggests that G13513A mutation is a frequent cause of LS and that patients with this mutation may have a characteristic clinical course.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14730434     DOI: 10.1007/s10038-003-0116-1

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  34 in total

1.  Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease.

Authors:  Denise M Kirby; Avihu Boneh; C W Chow; Akira Ohtake; Michael T Ryan; Dominic Thyagarajan; David R Thorburn
Journal:  Ann Neurol       Date:  2003-10       Impact factor: 10.422

2.  Subacute necrotizing encephalomyelopathy in an infant.

Authors:  D LEIGH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1951-08       Impact factor: 10.154

3.  Clinical spectrum of mitochondrial DNA mutation at base pair 8344.

Authors:  S F Berkovic; E A Shoubridge; F Andermann; E Andermann; S Carpenter; G Karpati
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

4.  Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  H Hasegawa; T Matsuoka; Y Goto; I Nonaka
Journal:  Ann Neurol       Date:  1991-06       Impact factor: 10.422

5.  A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis.

Authors:  D Thyagarajan; S Shanske; M Vazquez-Memije; D De Vivo; S DiMauro
Journal:  Ann Neurol       Date:  1995-09       Impact factor: 10.422

6.  Heterogeneous presentation in A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene.

Authors:  Y Koga; Y Akita; N Takane; Y Sato; H Kato
Journal:  Arch Dis Child       Date:  2000-05       Impact factor: 3.791

7.  Leigh disease associated with a novel mitochondrial DNA ND5 mutation.

Authors:  Robert W Taylor; Andrew A M Morris; Michael Hutchinson; Douglass M Turnbull
Journal:  Eur J Hum Genet       Date:  2002-02       Impact factor: 4.246

8.  Leigh syndrome: clinical features and biochemical and DNA abnormalities.

Authors:  S Rahman; R B Blok; H H Dahl; D M Danks; D M Kirby; C W Chow; J Christodoulou; D R Thorburn
Journal:  Ann Neurol       Date:  1996-03       Impact factor: 10.422

9.  Confirmation that a T-to-C mutation at 9176 in mitochondrial DNA is an additional candidate mutation for Leigh's syndrome.

Authors:  M Makino; S Horai; Y Goto; I Nonaka
Journal:  Neuromuscul Disord       Date:  1998-05       Impact factor: 4.296

10.  Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency.

Authors:  V Tiranti; K Hoertnagel; R Carrozzo; C Galimberti; M Munaro; M Granatiero; L Zelante; P Gasparini; R Marzella; M Rocchi; M P Bayona-Bafaluy; J A Enriquez; G Uziel; E Bertini; C Dionisi-Vici; B Franco; T Meitinger; M Zeviani
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

View more
  14 in total

1.  Sequence polymorphisms of the mtDNA control region in a human isolate: the Georgians from Swanetia.

Authors:  Miguel A Alfonso-Sánchez; Cristina Martínez-Bouzas; Azucena Castro; Jose A Peña; Isabel Fernández-Fernández; Rene J Herrera; Marian M de Pancorbo
Journal:  J Hum Genet       Date:  2006-04-01       Impact factor: 3.172

2.  Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA.

Authors:  Yann Tonin; Anne-Marie Heckel; Mikhail Vysokikh; Ilya Dovydenko; Mariya Meschaninova; Agnès Rötig; Arnold Munnich; Alya Venyaminova; Ivan Tarassov; Nina Entelis
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

3.  Leigh Syndrome Caused by the MT-ND5 m.13513G>A Mutation: A Case Presenting with WPW-Like Conduction Defect, Cardiomyopathy, Hypertension and Hyponatraemia.

Authors:  Marcus Brecht; Malcolm Richardson; Ajay Taranath; Scott Grist; David Thorburn; Drago Bratkovic
Journal:  JIMD Rep       Date:  2015-02-15

4.  Uncommon mutation in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS).

Authors:  Jasna David; Julie Omolola Okiro; Kevin Murphy; Marwa Elamin
Journal:  BMJ Case Rep       Date:  2017-02-27

5.  Mutations in the ND5 subunit of complex I of the mitochondrial DNA are a frequent cause of oxidative phosphorylation disease.

Authors:  M J Blok; L Spruijt; I F M de Coo; K Schoonderwoerd; A Hendrickx; H J Smeets
Journal:  J Med Genet       Date:  2007-04       Impact factor: 6.318

6.  Mitochondrial m.13513G>A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing.

Authors:  Daniel Vázquez-Justes; Lidia Carreño-Gago; Elena García-Arumi; Alicia Traveset; Julio Montoya; Eduardo Ruiz-Pesini; Ricard López; Luis Brieva
Journal:  J Pediatr Genet       Date:  2019-05-28

7.  Case Report: Optic Atrophy and Nephropathy With m.13513G>A/MT-ND5 mtDNA Pathogenic Variant.

Authors:  Valentina Barone; Chiara La Morgia; Leonardo Caporali; Claudio Fiorini; Michele Carbonelli; Laura Ludovica Gramegna; Fiorina Bartiromo; Caterina Tonon; Luca Morandi; Rocco Liguori; Aurelia Petrini; Rachele Brugnano; Rachele Del Sordo; Carla Covarelli; Manrico Morroni; Raffaele Lodi; Valerio Carelli
Journal:  Front Genet       Date:  2022-06-03       Impact factor: 4.772

8.  Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Ester Perales-Clemente; Xing Li; Amber McDonald; Devin Oglesbee; Sybil C Hrstka; Carmen Perez-Terzic; Andre Terzic; Timothy J Nelson
Journal:  Stem Cells       Date:  2013-07       Impact factor: 6.277

9.  The 13042G --> A/ND5 mutation in mtDNA is pathogenic and can be associated also with a prevalent ocular phenotype.

Authors:  M L Valentino; P Barboni; C Rengo; A Achilli; A Torroni; R Lodi; C Tonon; B Barbiroli; F Fortuna; P Montagna; A Baruzzi; V Carelli
Journal:  J Med Genet       Date:  2006-07       Impact factor: 6.318

10.  Association of mitochondrial genetic variation with carotid atherosclerosis.

Authors:  Igor A Sobenin; Margarita A Sazonova; Anton Y Postnov; Jukka T Salonen; Yuri V Bobryshev; Alexander N Orekhov
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.